Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-02

Clinical Trial Update: A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing azilsartan to telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes; study completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azilsartan (azilsartan)
  • Telmisartan (Telmisartan)

Snippet

Sponsor: Takeda | Conditions: Essential Hypertension Complicated by Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2017-08-02